Telaprevir Clinical Trial Participants - San Francisco

[Guest guest]

We are conducting a study on Hepatitis C in San Francisco next week and seek

your help in getting this opportunity out to the community. Sorry, I know it is

short notice!

In this case we specifically seek those that have participated in a clinical

trial (past or present), triple combination therapy

(Pegasys+Ribavirin+Telaprevir). Co-infected is fine. It is not necessary to be

currently taking but have in the past. Must have been on all three of these

drugs at the same time at some point.

The objective is to discover what their experience with this combo therapy was

like and to improve future drugs in development to treat HCV. Telaprevir will be

discussed.

Interviews 90 minutes in San Francisco, downtown, on Tuesday 5/10.

Participants receive $200 cash.

Please respond to with interest or questions to contacts below.

Kind Regards,

Jan

Jan Mallery-Groom RN

Clinical Research Support Services

+510-922-9710 / jmallery@...